Stock Ratings / Health Care / ELMD / dividends

FOCL (29) HSDT (37) CV (44) VANI (34) ⌘ Pro Terminal →

Electromed Inc. (ELMD) Dividend Safety Gauge & 10-Year DRIP Compounder

$27.68 +1.47% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $27.82

Electromed Inc. (ELMD) earns a Roarable Rating of B+ (Buy) with 77/100 RQD Confidence. High-quality cash engine (78% profit margin, 24% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

📊 Historical Track Record: Scores of 77/100 (B+) historically ranked in the Top 10% of excess returns over the next 90 days (+7.8% avg 90D alpha vs SPY • 70.3% hit rate) →

ROARABLE B+ • BUY Cap $229.4M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on ELMD Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is ELMD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-01, Electromed Inc. (NYSE: ELMD) is rated B+ (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 77/100 at a spot price of $27.68 (+1.47% 1D, market cap $229.4M). Pillar breakdown: Fundamental Cash Engine 17/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 16/20. Across 1016 tracked Health Care issuers, ELMD ranks #31 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does ELMD compare to FOCL and HSDT in the Health Care sector?

▼

Within the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus), ELMD carries a Roarable B+ (77/100 RQD), trailing P/E of 30.4x, gross margin of 78.1%, and ROIC of 24.1%. By comparison, FOCL (EDAP TMS S.A.) holds a E grade (29/100 RQD, P/E N/A, ROIC -35.0%, cap $191.6M) and HSDT (Solana Company (Class A)) posts a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $146.5M). Among the 5-stock peer group, VANI leads on earnings multiple (3.9x) while ELMD leads on capital efficiency (24.1% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for ELMD?

▼

Per ELMD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0001488917), Electromed Inc. generated $64.0M in revenue (+17.0% YoY), $7.5M in net income, and $11.1M in free cash flow against $54.9M in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (78% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $27.82 (+0.50%)🧬 Cannibal Buyback (-2.36% YoY Shares)⚙️ Cash Engine: 17/20 (A-) • 17.4% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 77/100 (B+) historically ranked in the Top 10% of excess returns over the next 90 days (+7.8% avg 90D alpha vs SPY • 70.3% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERBUY • B+

3-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B · Rk A-

Each axis scored 0–20

12M PRICE TARGET CONE+8.6% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ELMD)Realized 20D OHLCV Swing Band: ±6.3%

Deterministic 5-Pillar Attribution (77/100 Composite)

🔍 WHY ELMD SCORES 77/100 (B+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (23% of score)

Altman Z-Score 17.64 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9

▲ #2 Bullish Driver: Cash Engine Quality+17/20 pts (22% of score)

SEC XBRL FY 2025 (10-K): 17.4% FCF Margin ($11.1M FCF) & 78.1% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning11/20 pts (-9 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-9 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade A$27.69-1% Next Q

Q2 (-2Q)

Grade A$27.42-3.8% Next Q

Q3 (-1Q)

Grade A-$26.37+5% Next Q

Current

Grade B+$27.68+7.8% Hist 90D α

Trajectory: A (85) → B+ (77)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the ELMD Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 77/100 (B+) score, ELMD faces multiple-compression risk if 30.4x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.36% YoY Shares) — any gross margin slip below 75.6% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($28.37) or 200D SMA ($31.28) invalidates the momentum regime and cuts Target Base ($30.05) toward Bear Floor ($22.70).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ELMD• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “ELMD Beats Next Quarter EPS Consensus (Dec 28, 2026) & Holds Above 200D SMA”

YES 77%NO 23%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

1.8% Total Yield

0% Cash ($0.00/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (11.2% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $28,910

Est. Year-10 Shareholder Yield: $520/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$11.1K

Yr 1

$12.4K

Yr 2

$13.8K

Yr 3

$15.3K

Yr 4

$17.0K

Yr 5

$18.9K

Yr 6

$21.0K

Yr 7

$23.4K

Yr 8

$26.0K

Yr 9

$28.9K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Cash-Flow & Quality Compounder Desk

Cash-Fortress Compounders: Auditing Free Cash Flow & Yield Safety in ELMD & A-Rated Leaders

✓12-month Bull/Base/Bear fair-value walkthrough on ELMD and its top sector peer
✓Top Roarable A-Rated cash compounders with verified executive & 13F accumulation
✓Includes nightly RQD rating-change & forensic signal email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

ELMD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +7.66%🛡️ HOLDING TREND SUPPORT

2026-10-30O $27.95H $28.07L $26.87C $27.68VOL 36.4K

RES: $36.28SUP: $26.27SMA50: $28.37SMA200: $31.28

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ELMD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ELMD Butterfly Map → + Track ELMD →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

23.5%/yr Implied 5Y Growth

vs. +17.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ELMD today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ELMD. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for ELMD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ELMD)

Health Care Rank #31 of 1016 ⚔️ FOCL vs ELMD Full Matrix →

1. Head-to-Head Health Care Peer Comparison (ELMD vs. FOCL, HSDT, CV, VANI)

Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus (26 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Electromed Inc. (ELMD) ranks #31 by composite RQD confidence (77/100, grade B+) and #557 by equity capitalization ($229.4M). Within this direct 5-issuer industry benchmark cohort, VANI leads on earnings valuation at 3.9x trailing P/E, while ELMD leads on capital efficiency and profitability with 24.1% ROIC and 78.1% gross margin. ELMD currently leads its immediate peer cohort in composite quantitative strength at 77/100 (B+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
ELMD ACTIVE Electromed Inc.	B+	77/100	30.4x	78.1%	24.1%	+1.47%	$229.4M	Benchmark Subject
FOCL EDAP TMS S.A.	E	29/100	—	42.5%	-35.0%	-2.11%	$191.6M	/focl-vs-elmd →
HSDT Solana Company (Class A)	D-	37/100	—	96.0%	-35.0%	-1.31%	$146.5M	/hsdt-vs-elmd →
CV CapsoVision Inc.	D	44/100	—	52.9%	-35.0%	-1.70%	$369.2M	/cv-vs-elmd →
VANI Vivani Medical Inc.	E	34/100	3.9x	—	-35.0%	0.00%	$102.8M	/vani-vs-elmd →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-06-30 • CIK 0001488917

In its most recent audited fiscal period (FY2025, filed 2025-06-30), Electromed Inc. (ELMD) reported GAAP revenue of $64.0M (+17.0% vs. FY2024 revenue of $54.7M , and +33.1% cumulative change since FY2023) , GAAP net income of $7.5M, operating cash flow of $11.4M, and free cash flow of $11.1M (+26.8% YoY). On the balance sheet, ELMD closed FY2025 with $54.9M in total assets against $0 in total debt (Altman Z-Score: 17.64, Piotroski F-Score: 8/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-06-30	$64.0M	$7.5M	$11.4M	$11.1M	$54.9M	—
FY2024 (FY)	2024-06-30	$54.7M	$5.2M	$9.1M	$8.8M	$52.3M	—
FY2023 (FY)	2023-06-30	$48.1M	$3.2M	$1.3M	$1.3M	—	—

3. ELMD Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ELMD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does ELMD compare to FOCL and HSDT in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for ELMD?

Where is ELMD trading relative to its 50-day, 200-day, and 52-week technical levels?

ELMD last traded at $27.68 (+1.47% on volume of 26,910 shares), positioning the stock -2.43% below its 50-day simple moving average ($28.37) and -11.51% below its 200-day simple moving average ($31.28). Across its 52-week range of $23.01 to $47.40, ELMD sits at the 19.1% percentile with a 14-day RSI of 42.0 (NEUTRAL RANGE) and an implied next-earnings move of ±6.3% ($25.94 to $29.42).

ELMD Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does ELMD pay a dividend and is it safe?

Electromed Inc. (ELMD) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Direct Sub-Reports: ELMD RQD Cockpit ELMD 12M Forecast ELMD Earnings & Move ELMD Dividends & DRIP ELMD Insiders & 13F ELMD Whale Options ELMD Profit Sankey ELMD News & Why